| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/27/2000 | CA2346799A1 Delivery system for porcine somatotropin |
| 04/27/2000 | CA2346798A1 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | CA2346656A1 Methods of hydrating mucosal surfaces |
| 04/27/2000 | CA2345205A1 Polyvinyl alcohol microspheres, and methods for making and therapeutic uses of the same |
| 04/26/2000 | EP0995757A2 Bivalent inhibitors of the proteasome |
| 04/26/2000 | EP0995435A1 Aqueous suspension preparations with excellent redispersibility |
| 04/26/2000 | EP0994959A1 Polymer-modified viruses |
| 04/26/2000 | EP0994887A2 Modified glycosides, compositions comprised thereof and methods of use thereof |
| 04/26/2000 | EP0994727A1 Process for solubilizing pharmaceutically active ingredients in water and in aqueous vehicles |
| 04/26/2000 | EP0994726A2 Compositions suitable for delivery of genes to epithelial cells |
| 04/26/2000 | EP0994720A1 Use of bromelain in the manufacture of a medicament for enhancement of intestinal permeability |
| 04/26/2000 | EP0994710A1 Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
| 04/26/2000 | EP0994701A1 Block copolymer |
| 04/26/2000 | EP0994700A1 Methods of removing residual solvent from nasal drug delivery compositions |
| 04/26/2000 | EP0994696A1 Controlled release pharmaceutical preparation with ace inhibitor as active agent |
| 04/26/2000 | EP0994693A2 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin |
| 04/26/2000 | EP0983037A4 Antifungal nail lacquer and method using same |
| 04/26/2000 | EP0771209A4 Novel peptides |
| 04/26/2000 | EP0589871B1 Peritoneal induced medicaments |
| 04/26/2000 | EP0511292B1 Polyanhydrides of the oligomerized unsaturated aliphatic acids |
| 04/26/2000 | CN1251532A Tissue factor methods and compositions for coagulation and tumor treatment |
| 04/26/2000 | CN1251524A Pharmaceutical composition for oral administration of N-piperidino-3-phrazolecarboxamide derivative, its salts and their solvates |
| 04/26/2000 | CN1251312A Stable complex of insoluble chemical compound |
| 04/26/2000 | CN1251297A Benzimidazole enteric coating preparation and preparing method thereof |
| 04/25/2000 | US6054555 Process for the preparation of immobilized and activity-stabilized complexes of LHRH antagonists |
| 04/25/2000 | US6054511 Aqueous cellulose composition of at least one cellulose ether from specific ones, such as cationic hydroxyethyl cellulose, methyl cellulose, methyl hydroxypropyl cellulose, carboxymethyl hydroxyethyl cellulose; use as fluid additive |
| 04/25/2000 | US6054492 Fluorinated copolymeric pharmaceutical adjuncts |
| 04/25/2000 | US6054485 Eye treatments using synthetic thyroid hormone compositions |
| 04/25/2000 | US6054484 Transparent aqueous solution of diclofenac sodium and medicinal compositions with the use of the same |
| 04/25/2000 | US6054482 Hydrolysis of gabapentin or the lactam to form acid addition salt, conversion to pure compound by ion exchanging; antiepileptic agents |
| 04/25/2000 | US6054462 Intranasal antimigraine compositions |
| 04/25/2000 | US6054436 Regulated apoptosis |
| 04/25/2000 | US6054312 Receptor-mediated gene delivery using bacteriophage vectors |
| 04/25/2000 | US6054288 Drug delivery to mammalian cells; obtaining cells from a mammal, transfecting cells with vector epressing therapy agent, culturing transfected cells, introducing transfected cells into a mammal |
| 04/25/2000 | US6054143 Xylitol delivery |
| 04/25/2000 | US6054142 Biocompatible devices with foam scaffolds |
| 04/25/2000 | US6054140 Long acting injectable parasiticidal composition and the process for its preparation |
| 04/25/2000 | US6054138 Stabilized pseudo-emulsions and their preparation process |
| 04/25/2000 | US6054133 Anti-microbial targeting for intracellular pathogens |
| 04/25/2000 | US6054127 A therapeutic treatment for cocaine addiction; the conjugate capable of stimulating the production of anti-hapten antibodies; a therapeutic immunization regimen elicits anti-drug antibodies |
| 04/25/2000 | US6054122 A foamable fibrin matrix comprising fibrinogen or metabolite and an foaming agent which causes fibrinogen to foam during application of fibrinogen to wounded tissue |
| 04/25/2000 | CA2181241C Process for solubilizing difficultly soluble pharmaceutical actives |
| 04/25/2000 | CA2155728C Regulated transcription of targeted genes and other biological events |
| 04/25/2000 | CA2106079C Pegylation of polypeptides |
| 04/25/2000 | CA2098021C Composition used as a therapeutic agent against chronic viral hepatic diseases |
| 04/25/2000 | CA2070095C Microspheres containing biologically-active components, processes for the preparation and uses |
| 04/25/2000 | CA1340977C Scavenger receptor protein and antibody thereto |
| 04/20/2000 | WO2000022112A1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 04/20/2000 | WO2000022110A2 Targeted proteolysis by recruitment to ubiquitin protein ligases |
| 04/20/2000 | WO2000022103A1 A modified polypeptide with reduced immune response |
| 04/20/2000 | WO2000021964A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and anfiinflammatory activity |
| 04/20/2000 | WO2000021952A1 Quinoline derivatives and their use as antibacterial agents |
| 04/20/2000 | WO2000021883A1 Silicon dioxide with mesopores and micropores |
| 04/20/2000 | WO2000021574A2 Site-directed dual pegylation of proteins |
| 04/20/2000 | WO2000021573A1 Site-specific labeling of disulfide-containing targeting vectors |
| 04/20/2000 | WO2000021572A2 Hydrogels and water soluble polymeric carriers for drug delivery |
| 04/20/2000 | WO2000021571A1 Ion exchange tumor targeting (iett) |
| 04/20/2000 | WO2000021569A2 Macromolecular active substance conjugates and a method for the production thereof |
| 04/20/2000 | WO2000021568A1 Fibrin glue as a biological adjuvant |
| 04/20/2000 | WO2000021567A1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 04/20/2000 | WO2000021566A1 Sorbefacients and preparations for percutaneous absorption containing the same |
| 04/20/2000 | WO2000021560A1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 04/20/2000 | WO2000021541A1 Process for the preparation of oral pharmaceutical compositions comprising biphosphonates |
| 04/20/2000 | WO2000021540A1 Compositions containing diphosphonic acids |
| 04/20/2000 | WO2000021533A1 A dried or frozen pharmaceutical preparation containing a class iii antiarrhythmic compound |
| 04/20/2000 | WO2000021525A2 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 04/20/2000 | WO2000021521A2 Sertraline oral concentrate |
| 04/20/2000 | WO2000021520A2 Opioid analgesic |
| 04/20/2000 | WO2000021510A2 Formulations of fexofenadine |
| 04/20/2000 | WO2000021505A2 Composition for the parenteral administration of active agents |
| 04/20/2000 | WO2000021504A1 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles |
| 04/20/2000 | WO2000021503A1 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 04/20/2000 | WO2000021491A1 Stable oil-in-water emulsion, method for preparing same and use in cosmetics and dermatology |
| 04/20/2000 | WO2000021370A1 Oligonucleotide delivery systems for camptothecins |
| 04/20/2000 | WO2000004052A3 Soluble derivatives of anti-angiogenic peptides |
| 04/20/2000 | WO2000003737A3 Water-soluble drugs and methods for their production |
| 04/20/2000 | WO2000002999A3 Medium and matrix for long-term proliferation of cells |
| 04/20/2000 | WO1999064050A9 Novel potassium channel drugs and their uses |
| 04/20/2000 | WO1999064000A9 Novel therapeutic agents that modulate neurokinin receptors |
| 04/20/2000 | WO1999063981A3 Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells |
| 04/20/2000 | DE19847969A1 Stable liquid formulation of formoterol in solution or suspension medium, used after dilution for treatment of asthma by inhalation |
| 04/20/2000 | DE19847968A1 Separate storage of an active material and a solvent comprises a closure cap and a container, with a chamber attached to the unit. |
| 04/20/2000 | DE19847630A1 Silica having mesopores and micropores, useful for making catalysts, catalyst supports or carriers for pharmacologically active substances, enzymes or pigments |
| 04/20/2000 | DE19847593A1 Parenteral drug administration composition with depot and controlled release comprises active agent and water soluble polysaccharide microparticles as carrier |
| 04/20/2000 | DE19847362A1 New polycyclic aromatic compound-protein conjugates, useful for detection and/or treatment of diseased tissue, e.g. tumors or inflammation sites |
| 04/20/2000 | DE19847137A1 Use of 9.10-dihydro-9-oxa-10-phospha-phenenthrene 10-oxide as antioxidant, e.g. for polymers, fats, oils, functional fluids, foods, animal feeds, pharmaceuticals and cosmetics |
| 04/20/2000 | DE19846537A1 Betaine Betaine |
| 04/20/2000 | CA2346929A1 A modified polypeptide with reduced immune response |
| 04/20/2000 | CA2346892A1 Silicon dioxide having mesopores and micropores |
| 04/20/2000 | CA2346670A1 Composition for the parenteral administration of active compounds |
| 04/20/2000 | CA2346542A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and antiinflammatory activity |
| 04/20/2000 | CA2346329A1 Hydrogels and water soluble polymeric carriers for drug delivery |
| 04/20/2000 | CA2346307A1 Formulations of fexofenadine |
| 04/20/2000 | CA2346122A1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 04/20/2000 | CA2346066A1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 04/20/2000 | CA2315375A1 A dried or frozen pharmaceutical preparation containing a class iii antiarrhythmic compound |
| 04/20/2000 | CA2312032A1 Stable oil-in-water emulsion, method for preparing same and use in cosmetics and dermatology |
| 04/19/2000 | EP0993831A2 Compounds and compositions for delivering active agents |
| 04/19/2000 | EP0993830A2 New stabilized galenic formulations comprising an acid labile benzimidazole compound and its preparation |
| 04/19/2000 | EP0993825A2 Urea containing composition and its cosmetic and dermatologic use |